Funding Alzheimer’s Research
Funding Alzheimer’s Research
The FY 2017 Omnibus spending bill, signed into law on May 5, 2017, secured $34.1 billion for the National Institutes of Health (NIH), of which $1.4 billion is dedicated to Alzheimer’s disease research. The $1.4 billion is the result of an additional $400 million to FY 2016 funding levels, a 40% boost.
While the President’s proposed FY 2018 budget cuts $6 billion in funding for NIH, the House Appropriations Committee’s Labor, Health and Human Services, and Education funding bill proposed a $1.1 billion increase in NIH funding – which would bring total NIH funding up to $35.2 billion.
The proposed funding increase includes an additional $400 million for Alzheimer’s research. If this funding increase were to pass, it would bring NIH funding dedicated to Alzheimer’s research up to $1.8 billion.
As the appropriations process proceeds, we will continue to work with Congressional leaders to secure robust funding for Alzheimer’s research and federal programs that improve and expand access to care.
Read our full appropriations priorities here
Protecting the Affordable Care Act
On May 4, 2017, the House of Representatives narrowly passed the American Health Care Act (AHCA) with several amendments which would undermine the Affordable Care Act (ACA). The AHCA will harm Californians by:
- Slashing Medicaid funding, forcing California to cut services, restrict eligibility and reduce benefits.
- Putting access to long-term services and supports at jeopardy.
- Charge older Californians more.
- Eliminate protections for people with pre-existing conditions.
The Senate recently released its version of the bill, which proposes greater cuts in Medicaid funding. Harsher caps will force steeper cuts for California—putting our most vulnerable at greater risk and threating our entire health system.
The Affordable Care Act has implemented important benefits for people living with Alzheimer’s and dementia.
Some of those benefits include:
- Free annual Medicare wellness visit that includes a cognitive assessment
- Expanding coverage of Medicare prescription drugs to eliminate the “donut hole”
- Health insurance companies cannot refuse coverage based on pre-existing conditions, which protects people with early-onset dementia from discrimination.
In addition, ACA funding has supported work here at Alzheimer’s Greater Los Angeles such as our award winning Dementia Cal MediConnect project. Thanks to this funding, our staff has trained case managers at health plans in the greater Los Angeles area to better serve people with dementia and their caregivers.
But we will only be successful in our advocacy efforts if you speak up. We need YOU to tell the new President and Congress to support the programs our families rely upon every day and to fund the Alzheimer’s research that our scientists need to find a cure. So keep your eye out for our AlZGLA advocacy emails and then pick up the phone, send an email, or make a visit to your Member of Congress to tell them we are relying on them to lift our families up, not pull the rug out from under their feet.
For more information about the impact of the Affordable Care Act on people with Alzheimer’s disease or other forms of dementia, please read the Leaders Engaged on Alzheimer’s Coalition issue brief here.
The National Alzheimer’s Summit
Join us in Washington D.C., October 3-5, 2017 for UsAgainstAlzheimer’s National Alzheimer’s Summit: Uniting Communities for a cure. Leaders and advocates from diverse communities impacted by the disease will work together to develop a clear agenda for action with a focus on early prevention, caregiving programs and patient voices. The summit includes the 2nd Annual Diversifying the Race for a Cure & Care Symposium, the 4th Annual Out of the Shadows Dinner and a Capitol Hill Day.
Alzheimer’s Greater Los Angeles advocates who are interested in attending should contact Barbra McLendon. We will be offering limited scholarship funds to partially reimburse participants. If you would like to apply for a scholarship, please fill out this form and return to firstname.lastname@example.org by Monday, August 28.